| Ontology | CARD's Antibiotic Resistance Ontology |
| Accession | ARO:3004120 |
| Definition | CBP C1-aminomethylene vancomycin is a synthetic vancomycin derivative which exhibits multiple synergistic mechanisms of action, allowing it to effectively inhibit otherwise-glycopeptide resistant Gram-positive bacteria (notably those with functioning VanA clusters). |
| SMILES | N/A |
| Drug Class | peptide antibiotic, nonribosomal peptide antibiotics, glycopeptide antibiotic |
| Classification | 4 ontology terms | Show + process or component of antibiotic biology or chemistry + antibiotic molecule + peptide antibiotic [Drug Class] + nonribosomal peptide antibiotics [Drug Class] |
| Parent Term(s) | 1 ontology terms | Show + glycopeptide antibiotic [Drug Class] |
| Publications | Okano A, et al. 2017. Proc. Natl. Acad. Sci. U.S.A. : Peripheral modifications of [Ψ[CH2NH]Tpg(4)]vancomycin with added synergistic mechanisms of action provide durable and potent antibiotics. (PMID 28559345) |
| Curator | Description | Most Recent Edit |
|---|